The Comparison of Socio-Demographic and Clinical Variables of Inmates Using Gabapentin For Medicinal Purposes and Those Abusing The Drug

Basit Öğe Kaydı
dc.contributor.authorCicekci, Faruk
dc.contributor.authorYuksekkavas, Dincer
dc.contributor.authorAydin, Adem
dc.contributor.authorKaraibrahimoglu, Adnan
dc.contributor.authorUca, Ali Ulvi
dc.date.accessioned2020-03-26T19:42:48Z
dc.date.available2020-03-26T19:42:48Z
dc.date.issued2017
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractObjective: To compare the socio-demographic and clinical data of inmates using gabapentin for medicinal purposes and those abusing the drug. Methods: The study included inmates of the Konya E-Type Prison who used gabapentin between June 2012 and December 2014 and were admitted to the prison polyclinic. The participants were divided into two groups; those using gabapentin due to existing symptoms without any labeled indication (Group 1), and those using the medication due to disorders with labeled indications (Group 2). Both groups were investigated in terms of drug addiction, drug abuse, and gabapentin abuse according to the Diagnostic and Statistical Manual-Text Revision (DSM IV-TR). Results: Nearly all inmates (n=21) using gabapentin with off-label indications (Group 1) reported using it due to muscle pain, neuropathic pain, sleep disorder, signs of anxiety, sweating, trembling, and nausea-vomiting, whereas those using gabapentin with labeled indications (Group 2) reported using it because of their diseases, such as diabetic neuropathy and epilepsy. Alcohol/substance abuse was found higher among the first-degree relatives of those using gabapentin with off-label indications (P < 0.001). The rates of substance dependence (n=10) and substance abuse (n=13) were significantly higher in Group 1 than in Group 2 (P < 0.001). Conclusion: The inmates who were diagnosed as having drug addiction and substance abuse according to the DSM-IV-TR used gabapentin after entering prison to prevent opioid withdrawal symptoms.en_US
dc.identifier.doi10.24165/jns.10014.17en_US
dc.identifier.endpage251en_US
dc.identifier.issn1302-1664en_US
dc.identifier.issue3en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage242en_US
dc.identifier.urihttps://dx.doi.org/10.24165/jns.10014.17
dc.identifier.urihttps://hdl.handle.net/20.500.12395/35526
dc.identifier.volume34en_US
dc.identifier.wosWOS:000412947000006en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherJOURNAL NEUROLOGICAL SCIENCESen_US
dc.relation.ispartofJOURNAL OF NEUROLOGICAL SCIENCES-TURKISHen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectGabapentinen_US
dc.subjectinmatesen_US
dc.subjectsubstance abuseen_US
dc.subjectsubstance addictionen_US
dc.titleThe Comparison of Socio-Demographic and Clinical Variables of Inmates Using Gabapentin For Medicinal Purposes and Those Abusing The Drugen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu